TickerFacts.

Lantheus Holdings, Inc. (LNTH): EPS (Diluted)

Annual figures by period end, from SEC filings.

$3.41
Year ended 2025-12-31
+104.3%
3-year compound annual growth
$4.652014-12-31: -$0.202015-12-31: -$0.602016-12-31: $0.822017-12-31: $3.172018-12-31: $1.032019-12-31: $0.792020-12-31: -$0.252021-12-31: -$1.062022-12-31: $0.402023-12-31: $4.652024-12-31: $4.362025-12-31: $3.41$3.41
2014-12-31 EPS (Diluted) (USD per share) 2025-12-31
Period endedEPS (Diluted)Change YoYSource filing
2025-12-31$3.41-21.8%2026-02-26, From 2025-01-01
2024-12-31$4.36-6.2%2026-02-26, From 2024-01-01
2023-12-31$4.65n/m2026-02-26, From 2023-01-01
2022-12-31$0.40n/m2025-02-26, From 2022-01-01
2021-12-31-$1.06n/m2024-02-22, From 2021-01-01
2020-12-31-$0.25n/m2023-02-23, From 2020-01-01
2019-12-31$0.79-23.3%2022-02-24, From 2019-01-01
2018-12-31$1.03-67.5%2021-02-25, From 2018-01-01
2017-12-31$3.17+286.6%2020-02-25, From 2017-01-01
2016-12-31$0.82n/m2019-02-20, From 2016-01-01
2015-12-31-$0.60n/m2018-02-26, From 2015-01-01
2014-12-31-$0.20n/a2017-02-23, From 2014-01-01

EPS (Diluted) at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Diluted)Change YoY
Lantheus Holdings, Inc. (LNTH)2025-12-31$3.41-21.8%
QuidelOrtho Corp (QDEL)2025-12-28-$16.69n/m
Neogen Corp (NEOG)2026-05-31-$0.04n/m
Myriad Genetics Inc (MYGN)2025-12-31-$3.95n/m
Idexx Laboratories Inc (IDXX)2025-12-31$13.08+22.6%
Intellia Therapeutics, Inc. (NTLA)2025-12-31-$3.81n/m
Alpha Teknova, Inc. (TKNO)2025-12-31-$0.32n/m
Immucell Corp (ICCC)2025-12-31-$0.12n/m
Aspira Women's Health Inc. (AWHL)2025-12-31-$0.37n/m

Compare LNTH, QDEL, NEOG, MYGN side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗